Why the study?
Does BAF treatment during the subacute stage improve cardiac remodeling and dysfunction at the chronic stage after myocardial infarction?
Does BAF treatment during the subacute stage improve cardiac remodeling and dysfunction at the chronic stage after myocardial infarction?
Inhibition of granulation tissue cell apoptosis with BAF during the subacute stage of myocardial infarction improves chronic cardiac remodeling and dysfunction.
BAF may improve post-MI remodeling in animals; leaves open clinical translation.
The postinfarct treatment with BAF improved LV remodeling and dysfunction through inhibition of granulation tissue cell apoptosis. These findings imply a new therapeutic strategy against postinfarct heart failure.
No takes yet. Share an insight, caveat, or question.
Hayakawa et al. (2003) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: